SHE, Y.; LIU, Z. Effect of Peptide Drug Liraglutide Nano-Formulation Combined with Sodium-Glucose Cotransporter-2 Inhibitor on Blood Lipids in Patients with Type 2 Diabetes: Peptide Drug Liraglutide Nano-Formulation and Type 2 Diabetes. Cellular and Molecular Biology, [S. l.], v. 68, n. 3, p. 221–228, 2022. DOI: 10.14715/cmb/2022.68.3.25. Disponível em: https://mail.cellmolbiol.org/index.php/CMB/article/view/4332. Acesso em: 21 nov. 2024.